Literature DB >> 803978

Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.

R K Holmes, M L Vasil, R A Finkelstein.   

Abstract

Spontaneous and chemically induced mutants with reduced ability to produce cholera enterotoxin (choleragen) as an extracellular protein were isolated from Vibrio cholerae strains 569B Inaba, a classical cholera vibrio, and 3083-2 Ogawa, an El Tor vibrio. By qualitative and quantitative immunological assay in vitro such mutants could be separated into different classes characterized either by production of no detectable choleragen (tox minus), or of small quantities of extracellular choleragen, or of large quantities of cell-associated choleragen but little extracellular choleragen. Analysis of proteins in concentrated culture supernates by electrophoresis in polyacrylamide gels showed that cultures from tox minus strains lacked proteins with electrophoretic mobilities corresponding with choleragen or the spontaneously formed toxoid (choleragenoid). Infant rabbits infected with the tox minus strains remained asymptomatic or developed milder symptoms than rabbits infected with the tox+ parental strains. When symptoms of cholera developed after inoculation with tox minus mutants, detectable numbers of tox+ revertants could be isolated from the intestines of the infected animals. Two tox minus strains, designated M13 and M27, caused no sumptoms and showed no evidence of reversion to tox+ during single passage in infant rabbits, and mutant M13 also remained avirulent and stably tox minus during six cycles of serial passage in infant rabbits. Strains M13 and M27 were also noncholeragenic in acult rabbit ileal loops. Quantitative cultures of the intestines from infected infant rabbits demonstrated that the avirulent mutant M13 can multiply in vivo and can persist in the intestinal tract for at least 48 h.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803978      PMCID: PMC301783          DOI: 10.1172/JCI107962

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Experimental cholera in infant rabbits: a method for chemotherapeutic investigation.

Authors:  N K DUTTA; M K HABBU
Journal:  Br J Pharmacol Chemother       Date:  1955-06

2.  Mutation of bacteria at high levels of survival by ethyl methane sulphonate.

Authors:  A LOVELESS; S HOWARTH
Journal:  Nature       Date:  1959-12-05       Impact factor: 49.962

3.  An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane.

Authors:  S N DE; D N CHATTERJE
Journal:  J Pathol Bacteriol       Date:  1953-10

4.  Antigenic analysis by diffusion.

Authors:  C L OAKLEY; A J FULTHORPE
Journal:  J Pathol Bacteriol       Date:  1953-01

5.  Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).

Authors:  R A Finkelstein; M Boesman; S H Neoh; M K LaRue; R Delaney
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

6.  Crystalline cholera toxin and toxoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  Science       Date:  1972-02-04       Impact factor: 47.728

7.  PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.

Authors:  S MUKERJEE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

8.  Monospecific equine antiserum against cholera exo-enterotoxin.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

9.  SEGREGATION OF GENETIC FACTORS DURING RECOMBINATION IN VIBRIO CHOLERAE, STRAIN 162.

Authors:  K BHASKARAN
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Type II secretion and pathogenesis.

Authors:  M Sandkvist
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

4.  Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.

Authors:  V Baselski; R Briggs; C Parker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel.

Authors:  S P Sigel; R A Finkelstein; C D Parker
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.

Authors:  V L Miller; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Endochitinase is transported to the extracellular milieu by the eps-encoded general secretory pathway of Vibrio cholerae.

Authors:  T D Connell; D J Metzger; J Lynch; J P Folster
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

8.  Quantitative measurements of cholera enterotoxin in cultures of toxinogenic wild-type and nontoxinogenic mutant strains of Vibrio cholerae by using a sensitive and specific reversed passive hemagglutination assay for cholera enerotoxin.

Authors:  R K Holmes; W B Baine; M L Vasil
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  Radial passive immune hemolysis assay for detection of heat-labile enterotoxin produced by individual colonies of Escherichia coli or Vibrio cholerae.

Authors:  M G Bramucci; R K Holmes
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

10.  Isolation and characterization of Bordetella avium phase variants.

Authors:  C R Gentry-Weeks; D L Provence; J M Keith; R Curtiss
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.